** Shares of Alcidion Group ALC.AX rise 10.5% to A$0.085, their highest levels since April 1
** Stock set for its strongest session since April 10, if current trends hold
** The healthcare tech co upgrades its FY25 outlook to expect A$3 million ($1.93 million) in EBITDA and A$40.2 million in revenue
** Co also reports Q3 sales of A$48.8 million with about A$11.5 million to be recognised as FY25 revenue
** About 2.5 mln shares change hands, 2.5x the 30-day average of 983,699 shares
** Stock up 40% YTD, including current session's moves
($1 = 1.5581 Australian dollars)
(Reporting by Manasi Dasa in Bengaluru)
((Manasi.DasaSundeep@thomsonreuters.com;))